Hill-Rom Holdings Inc

Hill-Rom — Merger or Acquisition (September 2021)

5 slides from Hill-Rom's merger presentation, Sep 2, 2021

  1. Slide 1: Expanding Connected Care and Medical Innovation Globally: Baxter to Acquire Hillrom

    Expanding Connected Care and Medical Innovation Globally: Baxter to Acquire Hillrom1 Baxter Snapshot Mission: Save and Sustain Lives 50,000 Employees2 FY 2020 Net Sales $11.7 B Renal Care Medication Delivery Pharmaceuticals Clinical Nutrition Advanced Surgery Acute Therapies BioPharma Solutions Hill

  2. Slide 2: Additional Information About the Merger and Where to Find It

    Additional Information About the Merger and Where to Find It This communication relates to the proposed transaction involving Hillrom. This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase o

  3. Slide 3: Forward-Looking Statements

    Forward-Looking StatementsThis communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Statements concerning general economic conditions, our financial condition, results of operations, cash flows and business and our

  4. Slide 4: Baxter Forward-Looking Statements

    Baxter Forward-Looking StatementsThis communication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995, each as amended, concerning Baxter’s

  5. Slide 5: Baxter Forward-Looking Statements (cont'd)

    Baxter Forward-Looking Statements (cont’d)(xviii) the ability to enforce owned or in-licensed patents or the prevention or restriction of the manufacture, sale or use of products or technology affected by patents of third parties; (xix) global, trade and tax policies; (xx) any change in laws concern

Hill-Rom Holdings — Merger or Acquisition (September 2021) on 6ix